Literature DB >> 9168035

Interaction of dystrophin fragments with model membranes.

C DeWolf1, P McCauley, A F Sikorski, C P Winlove, A I Bailey, E Kahana, J C Pinder, W B Gratzer.   

Abstract

The interaction with membrane lipids of recombinant fragments of human dystrophin, corresponding to a single structural repeating unit of the rod domain, was examined. Surface plasmon resonance, constant-pressure isotherms in a Langmuir surface film balance, and interfacial rheology were used to observe binding of the polypeptides and its effects on the properties of the lipid film. Modification of the monolayer properties was found to depend on the presence of phosphatidylserine in the lipid mixture and on the native tertiary fold of the polypeptide; thus a fragment with the minimum chain length required for folding (117 residues) or longer caused a contraction of the surface area at constant pressure, whereas fragments of 116 residues or less had no effect. The full extent of contraction was reached at a surface concentration of lipid corresponding to an average area of about 42 A2 per lipid molecule. A dystrophin fragment with the native, folded conformation induced a large increase in surface shear viscosity of the lipid film, whereas an unfolded fragment had no effect. Within a wide range of applied shear, the shear viscosity remained Newtonian. Binding of liposomes to immobilized dystrophin fragments could be observed by surface plasmon resonance and was again related to the conformational state of the polypeptide and the presence of phosphatidylserine in the liposomes. Our results render it likely that intact dystrophin interacts directly and strongly with the sarcolemmal lipid bilayer and grossly modifies its material properties.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9168035      PMCID: PMC1184457          DOI: 10.1016/S0006-3495(97)78903-3

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  30 in total

1.  A truncated dystrophin lacking the C-terminal domains is localized at the muscle membrane.

Authors:  T R Helliwell; J M Ellis; R C Mountford; R E Appleton; G E Morris
Journal:  Am J Hum Genet       Date:  1992-03       Impact factor: 11.025

2.  Are cysteine-rich and COOH-terminal domains of dystrophin critical for sarcolemmal localization?

Authors:  D Récan; P Chafey; F Leturcq; J P Hugnot; N Vincent; F Tomé; H Collin; D Simon; P Czernichow; L V Nicholson
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

3.  Structural predictions for the central domain of dystrophin.

Authors:  R A Cross; M Stewart; J Kendrick-Jones
Journal:  FEBS Lett       Date:  1990-03-12       Impact factor: 4.124

4.  Bending undulations and elasticity of the erythrocyte membrane: effects of cell shape and membrane organization.

Authors:  K Zeman; H Engelhard; E Sackmann
Journal:  Eur Biophys J       Date:  1990       Impact factor: 1.733

5.  The molecular basis of erythrocyte shape.

Authors:  A Elgsaeter; B T Stokke; A Mikkelsen; D Branton
Journal:  Science       Date:  1986-12-05       Impact factor: 47.728

6.  Mechanical properties of normal and mdx mouse sarcolemma: bearing on function of dystrophin.

Authors:  O F Hutter; F L Burton; D L Bovell
Journal:  J Muscle Res Cell Motil       Date:  1991-12       Impact factor: 2.698

7.  Decreased osmotic stability of dystrophin-less muscle cells from the mdx mouse.

Authors:  A Menke; H Jockusch
Journal:  Nature       Date:  1991-01-03       Impact factor: 49.962

Review 8.  Phospholipid flippases.

Authors:  P F Devaux
Journal:  FEBS Lett       Date:  1988-07-04       Impact factor: 4.124

9.  Electrostatic coupling of spectrin dimers to phosphatidylserine containing lipid lamellae.

Authors:  R Maksymiw; S F Sui; H Gaub; E Sackmann
Journal:  Biochemistry       Date:  1987-06-02       Impact factor: 3.162

10.  Expression of recombinant dystrophin and its localization to the cell membrane.

Authors:  C C Lee; J A Pearlman; J S Chamberlain; C T Caskey
Journal:  Nature       Date:  1991-01-24       Impact factor: 49.962

View more
  7 in total

1.  Brain spectrin (fodrin) interacts with phospholipids as revealed by intrinsic fluorescence quenching and monolayer experiments.

Authors:  W Diakowski; A Prychidny; M Swistak; M Nietubyć; K Białkowska; J Szopa; A F Sikorski
Journal:  Biochem J       Date:  1999-02-15       Impact factor: 3.857

2.  Disease-proportional proteasomal degradation of missense dystrophins.

Authors:  Dana M Talsness; Joseph J Belanto; James M Ervasti
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-21       Impact factor: 11.205

3.  Spectrin-like repeats 11-15 of human dystrophin show adaptations to a lipidic environment.

Authors:  Joe Sarkis; Jean-François Hubert; Baptiste Legrand; Estelle Robert; Angélique Chéron; Julien Jardin; Eric Hitti; Elisabeth Le Rumeur; Véronique Vié
Journal:  J Biol Chem       Date:  2011-06-28       Impact factor: 5.157

4.  Dystrophin contains multiple independent membrane-binding domains.

Authors:  Junling Zhao; Kasun Kodippili; Yongping Yue; Chady H Hakim; Lakmini Wasala; Xiufang Pan; Keqing Zhang; Nora N Yang; Dongsheng Duan; Yi Lai
Journal:  Hum Mol Genet       Date:  2016-07-04       Impact factor: 6.150

Review 5.  Spectrin and phospholipids - the current picture of their fascinating interplay.

Authors:  Dżamila M Bogusławska; Beata Machnicka; Anita Hryniewicz-Jankowska; Aleksander Czogalla
Journal:  Cell Mol Biol Lett       Date:  2014-02-25       Impact factor: 5.787

Review 6.  The role of the dystrophin glycoprotein complex in muscle cell mechanotransduction.

Authors:  Darren Graham Samuel Wilson; Andrew Tinker; Thomas Iskratsch
Journal:  Commun Biol       Date:  2022-09-27

7.  DMD Mutations in 576 Dystrophinopathy Families: A Step Forward in Genotype-Phenotype Correlations.

Authors:  Jonas Juan-Mateu; Lidia Gonzalez-Quereda; Maria Jose Rodriguez; Manel Baena; Edgard Verdura; Andres Nascimento; Carlos Ortez; Montserrat Baiget; Pia Gallano
Journal:  PLoS One       Date:  2015-08-18       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.